News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1โ€“36
Matches
48
Sources here
22
Companies here
1
Search results Stored financial headlines

Active search

48 matching headlines

Ticker or company: HLNMain companies and provider mentions
Clear

J.P. Morgan flags negative catalyst at Haleon on weak sales momentum

Investing.com -- J.P. Morgan put "underweight" rated Haleon on negative Catalyst Watch ahead of its Oct. 29 results, saying third-quarter like-for-like sales growth is tracking at 3%, leaving the consumer health company at the bottom of its 3%-5% guidance range for a second straight โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Haleon is Buying Better Shelf Space, Can the Visibility Help it Against Procter & Gamble and Colgate-Palmolive?

Haleon plc (NYSE:HLN) is trying to win the US consumer-health market one shelf at a time. The Sensodyne and Advil owner has secured more prominent positions at Walmart Inc. (NYSE:WMT), Target Corporation (NYSE:TGT), and other major retailers by offering improved commercial terms, including lower โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon Turns to Weight-Loss Drug Users for its Next U.S. Growth Opportunity

Haleon plc (NYSE:HLN) is finding a new growth opportunity in the expanding U.S. population using GLP-1 weight-loss drugs such as Wegovy and Zepbound. According to Reuters, the company has been placing products that can address GLP-1-related side effects in both its normal store locations โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon And 2 British AI Healthcare Stocks To Watch

With UK gilt yields responding to shifting Bank of England expectations, investors are rethinking where dependable long term growth could come from. Healthcare companies using artificial intelligence to improve diagnosis and treatment sit at the crossroads of technology and essential services, which can matter โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Jefferies raises Haleon price target to 410p on margin strength

Jefferies raises Haleon price target to 410p on margin strength Proactive uses images sourced from Shutterstock Jefferies has raised its price target for Haleon (Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health company behind Sensodyne and Advil, to 410p from 400p, maintaining its Buy rating. โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes

LONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia

A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. โ€ฆ

HLN mentioned
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

FOUNDATION CONSUMER HEALTHCARE ANNOUNCES SENIOR LEADERSHIP CHANGES FOLLOWING STRATEGIC REPOSITIONING INTO WOMEN'S HEALTH

Following successful portfolio streamlining, Foundation Consumer Healthcare sharpens category focus on the high-growth women's health market with two senior leadership appointments. Rupa Bahri, former Haleon executive, has been appointed CEO. Founder and current CEO Greg Bradley will assume the role of chairman of the โ€ฆ

HLN mentioned
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Haleon Canada Appoints Daniela Cavinatto as General Manager

Haleon Canada Daniela CavinattoDaniela Cavinatto joins Haleon as General Manager, Canada MISSISSAUGA, Ontario, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Haleon, a leading global consumer company, today announced the appointment of Daniela Cavinatto as General Manager, Canada. Daniela joins Haleon with more than 25 years โ€ฆ

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks -0.7% ยท Next-week setup positive 56.3% HLN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context